Author:
Ou Yang,Tang Zhao-hui,Sun Lu,Yu Hai-yang,Li Jia,Zhao Mei-hui,Xu Hui
Funder
National Natural Science Foundation of China
Subject
Pharmaceutical Science,Pharmacology
Reference15 articles.
1. Advances in synthetic approaches for the preparation of combretastatin-based anti-cancer agents;Singh;Synthesis,2009
2. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature;Dark;Cancer Res,1997
3. A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin A-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer;Dowlati;Cancer Res,2002
4. Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers;Rajak;Curr Pharm Des,2013
5. Polymer-based prodrugs: improving tumor targeting and the solubility of small molecule drugs in cancer therapy;Dragojevic;Molecules,2015
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献